TAVI: is it time to move to intermediate risk patients?

European Days of the French Society of Cardiology 2016

Summary

Martine Gilard, France, assesses that it’s time to use TAVI not only for high-risk patients but also for intermediate-risk patients as well.

Today, the mortality rate with TAVI is equal if not inferior to the mortality rate with surgery. Thanks to considerable improvements in both devices (smaller devices create a lessened risk for vascular complications), in the level of experience in teams, and in patient selection, TAVI is now an option that should be considered for a wider range of patients.